GlassScriptPhysician profile
William J Athans
NPI 1063663672
$4,152.34
in general payments reported to CMS, 2019-2025
26 companies · $602 in 2025
The $602 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,603 · 2020: $78.27 · 2021: $1,595 · 2022: $153 · 2024: $121 · 2025: $602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $479 · Travel and Lodging: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $478.97 |
| Travel and Lodging | $244.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,495.70 | 2019-2025 | |
| Reel Surgical, INC. | $1,200.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $464.86 | 2019-2021 | |
| Smith+Nephew, INC. | $193.26 | 2019-2022 | |
| Bioventus LLC | $139.12 | 2022-2025 | Durolane, Xcell |
| Miach Orthopaedics, INC. | $104.67 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $76.10 | 2025 | |
| Pacira Therapeutics, INC. | $51.98 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $51.32 | 2021-2025 | Iovera, Zilretta, Exparel |
| Vericel Corporation | $49.99 | 2021-2022 | |
| Horizon Therapeutics Plc | $45.08 | 2020 | |
| Ethicon US, LLC | $29.21 | 2019-2020 | |
| Abbvie INC. | $29.08 | 2025 | |
| Innovation Technologies INC | $24.66 | 2022 | |
| Radius Health, INC. | $24.00 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $21.13 | 2025 | Xdemvy |
| Abbott Laboratories | $21.05 | 2021 | |
| Davol INC. | $20.45 | 2025 | Arista |
| Depuy Synthes Sales INC. | $18.45 | 2022 | |
| Guard Medical INC. | $16.32 | 2025 | Npseal |
| Ermi LLC | $16.17 | 2019 | |
| Theragen, INC. | $15.36 | 2022 | |
| Zyla Life Sciences, INC. | $13.05 | 2019 | |
| Heraeus Medical, LLC. | $12.74 | 2025 | |
| Ibsa Pharma INC. | $11.09 | 2021 | |
| Embody, INC. | $7.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Athans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.